Wolf Group Capital Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $351K | Buy |
17,111
+2,515
| +17% | +$51.5K | 0.12% | 119 |
|
|
2024
Q4 | $341K | Hold |
14,596
| – | – | 0.17% | 92 |
|
|
2024
Q3 | $341K | Sell |
14,596
-2,863
| -16% | -$66.9K | 0.16% | 93 |
|
|
2024
Q2 | $404K | Buy |
17,459
+2,863
| +20% | +$66.2K | 0.16% | 95 |
|
|
2024
Q1 | $341K | Hold |
14,596
| – | – | 0.16% | 93 |
|
|
2023
Q4 | $341K | Sell |
14,596
-233
| -2% | -$5.44K | 0.16% | 94 |
|
|
2023
Q3 | $302K | Buy |
14,829
+233
| +2% | +$4.74K | 0.14% | 98 |
|
|
2023
Q2 | $351K | Hold |
14,596
| – | – | 0.18% | 93 |
|
|
2023
Q1 | $340K | Sell |
14,596
-650
| -4% | -$15.1K | 0.17% | 92 |
|
|
2022
Q4 | $384K | Buy |
+15,246
| New | +$384K | 0.18% | 93 |
|
|
2022
Q2 | – | Sell |
-18,992
| Closed | -$654K | – | 111 |
|
|
2022
Q1 | $654K | Sell |
18,992
-31,423
| -62% | -$1.08M | 0.33% | 72 |
|
|
2021
Q4 | $2.21M | Buy |
50,415
+34,117
| +209% | +$1.49M | 0.36% | 71 |
|
|
2021
Q3 | $826K | Sell |
16,298
-491
| -3% | -$24.9K | 0.45% | 67 |
|
|
2021
Q2 | $874K | Buy |
16,789
+7,520
| +81% | +$391K | 0.47% | 64 |
|
|
2021
Q1 | $424K | Buy |
+9,269
| New | +$424K | 0.24% | 76 |
|